Navigation Links
Popular diabetes drug works differently than thought
Date:5/4/2010

CINCINNATIThe popular diabetes medication metformin works in different fashion than the current widely accepted view. This new finding could lead to wider use of the drugparticularly in people with cancer and diseases linked to TSC deficiency like tuberous sclerosis and lymphangioleiomyomatosis (LAM).

The results of this study, led by George Thomas, PhD, scientific director of UC's Metabolic Diseases Institute, are published in the May 5 edition of Cell Metabolism.

Metformin, marketed first by Bristol-Myers Squibb as Glucophage and now available in generic form and a number of combinations, is widely prescribed to people with type 2 diabetes and may be extended to the treatment of certain cancers. The drug blocks the production of glucose (sugar) and increases sensitivity to insulina hormone that converts sugar and other foods into energy within the body.

Researchers have thought that metformin, an energy-deprivation agent, disables the mTOR (mammalian target of rapamycin) complex by first activating the tuberous sclerosis complex (TSC) proteins through the enzyme AMPK.

Thomas' team determined that mTOR could actually be disabled without AMPK, and even without TSC. The team was able to determine that metformin works to knock out mTOR through another enzyme, RAG GTPase.

"We've poked a hole in dogma," says Thomas, a professor in the cancer and cell biology department. "Scientists can and should go back and ask about things they had crossed off their list."

The importance of this finding, says Thomas, is the possibility it holds for broader use of metformin.

"Metformin is already prescribed to 100 million people worldwide, and our study raises the question, 'Could this drug be used even more widely?'"

A drug like metformin, which improves insulin sensitivity, could be seen as a possible viable alternative to drugs that target mTOR, but that may have long-term deleterious effects on insulin production. Type 2 diabetes results from the body's inability to properly use insulin. If left unmanaged, diabetes can lead to vision loss, kidney failure, heart attack, stroke and nerve or blood vessel damage.


'/>"/>

Contact: Dama Kimmon
dama.kimmon@uc.edu
513-558-4519
University of Cincinnati Academic Health Center
Source:Eurekalert

Related medicine news :

1. The Diet Solution Program: Popular Online Weight Loss Program is Revised to Include More Metabolism Boosting Meals
2. Quantity, Not Quality, of Online Posts Builds Popularity
3. Passover paradox: The amazing popularity of kosher foods
4. Electronic Cigarettes Continue to Experience Popularity Growth
5. Future Apps Releases Major Update to its Popular iPhone Text to Speech App Speak it
6. "How Stupid Do They Think We Are?" --- Band Releases New Anthem in Support of Popular Citizens' Resistance
7. Intellimed's Popular Data Reporting Software IM-IC (Intelligent Client) Receives Latest Update
8. Personalized Live on-Demand Yoga Avatar Gains Popularity Amongst Users, Across all age Groups
9. Popular nanoparticle causes toxicity in fish, study shows
10. Popular Diet Plans Can Unclog Arteries
11. Americans Remain Split on Stalled Health Care Legislation, but Some Provisions Popular Among Majorities of Democrats, Independents and Republicans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... In Madeira Beach Florida, a small town with ... citizens formed an organization, Madeira Beach United, to oppose two development projects undertaken by ... center to a high rise urban environment. , According to the Tampa Bay ...
(Date:5/26/2016)... ... ... According to the Webster’s dictionary, a hippie is defined as someone who ... is going against the norm with a line of all-natural skincare that’s effective, afforable ... space is proud to announce its latest retail partnership with the Vitamin Shoppe. Launching ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... weekend to host their second pop-up shop for three consecutive weekends. The pop-up ... to the Santa Barbara community, a community full of women who appreciate the ...
(Date:5/26/2016)... Malvern, PA (PRWEB) , ... May 26, 2016 ... ... Sharon Wolf has been hired as FluidEdge’s Vice President of Business Intelligence and ... health analytics, Wolf has demonstrated success leading teams as a healthcare business and ...
(Date:5/25/2016)... ... 2016 , ... The United States Food and Drug Administration (FDA) has now ... women. To date, the company is the first and only manufacturer of low level ... with androgenetic alopecia. , “This new level of clearance substantiates what many physicians ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... 24, 2016 Dutch surgeons have launched a ... the world and treat patients on a global scale. Medical professionals ... Asia and the US have already signed ... and networking in a totally secure environment. Education  ... zone working together with a surgeon at Harvard to treat a ...
(Date:5/23/2016)... , May 23, 2016 Global ... 163 pages, profiles 12 companies and the Paclitaxel analysis ... figures on the industry and its players. ... comprehensive in nature, details the current state of the ... including definitions, classifications, applications and industry chain structure. The ...
(Date:5/23/2016)... , May 23, 2016 ... Size, Share, Development, Growth and Demand Forecast to ... and Other), by Application (Drug Discovery and Development, ... Users (Pharmaceuticals, Life Science and Biotechnology, Academic and ... Market Research, the global mass spectrometry market ...
Breaking Medicine Technology: